Hailife self-developed analyzer, equipped with advanced technology, can perform hematology, biochemistry and immune assay simultaneously on one platform, providing reliable support for daily diagnosis. Also, the portability and flexibility of Hailife analyzers break the limitation of usage scenarios which could be adopted inside and outside healthcare centers.
A reagent based on highly integrated active microfluidic chip technology, offering a cost-effective, high-performance solution for testing. With a focus on innovation and efficiency, our reagent is designed to simplify the testing process while delivering reliable and accurate results.
Shenzhen Hailife Biotechnology Co., Ltd., established in May 2020, is a state-recognized high-tech enterprise. The company has a strong R & D capability and technical strength, the core team is from well-known listed enterprises and famous universities at home and abroad, and more than 90% of the employees have a bachelor's degree or above. The company is committed to the development of a low-cost, high-performance benchtop multifunctional in vitro diagnostic testing platform (including instruments and supporting reagents) based on clinical needs.
Read More >